226 related articles for article (PubMed ID: 11426323)
1. CTLA-4 gene expression is influenced by promoter and exon 1 polymorphisms.
Ligers A; Teleshova N; Masterman T; Huang WX; Hillert J
Genes Immun; 2001 May; 2(3):145-52. PubMed ID: 11426323
[TBL] [Abstract][Full Text] [Related]
2. [Polymorphism A/G in position +49 of CTLA4 exon 1 in multiple sclerosis in Russians].
Andreevskiĭ TV; Sudomoina MA; Gusev EI; Boĭko AN; Alekseenkov AD; Favorova OO
Mol Biol (Mosk); 2002; 36(4):643-8. PubMed ID: 12173468
[TBL] [Abstract][Full Text] [Related]
3. CDS1 and promoter single nucleotide polymorphisms of the CTLA-4 gene in human myasthenia gravis.
Wang XB; Kakoulidou M; Qiu Q; Giscombe R; Huang D; Pirskanen R; Lefvert AK
Genes Immun; 2002 Feb; 3(1):46-9. PubMed ID: 11857062
[TBL] [Abstract][Full Text] [Related]
4. Increased total serum IgE levels in patients with asthma and promoter polymorphisms at CTLA4 and FCER1B.
Hizawa N; Yamaguchi E; Jinushi E; Konno S; Kawakami Y; Nishimura M
J Allergy Clin Immunol; 2001 Jul; 108(1):74-9. PubMed ID: 11447385
[TBL] [Abstract][Full Text] [Related]
5. [Studies on the genetic pathogenesis of myasthenia gravis caused by CTLA-4 gene polymorphism].
Mao HT; Wang XB; Zhang L; Gu HT
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Dec; 21(6):574-8. PubMed ID: 15583985
[TBL] [Abstract][Full Text] [Related]
6. Relation of three polymorphisms of the CTLA-4 gene in patients with Graves' disease.
Kouki T; Gardine CA; Yanagawa T; Degroot LJ
J Endocrinol Invest; 2002 Mar; 25(3):208-13. PubMed ID: 11936461
[TBL] [Abstract][Full Text] [Related]
7. A CTLA-4 gene polymorphism at position -318 in the promoter region affects the expression of protein.
Wang XB; Zhao X; Giscombe R; Lefvert AK
Genes Immun; 2002 Jun; 3(4):233-4. PubMed ID: 12058260
[TBL] [Abstract][Full Text] [Related]
8. Lack of association between an exon 1 CTLA-4 gene polymorphism A(49)G and multiple sclerosis in a Polish population of the Lower Silesia region.
Boćko D; Bilińska M; Dobosz T; Zołedziewska M; Suwalska K; Tutak A; Gruszka E; Frydecka I
Arch Immunol Ther Exp (Warsz); 2003; 51(3):201-5. PubMed ID: 12894875
[TBL] [Abstract][Full Text] [Related]
9. CTLA-4 in autoimmune diseases--a general susceptibility gene to autoimmunity?
Kristiansen OP; Larsen ZM; Pociot F
Genes Immun; 2000 Feb; 1(3):170-84. PubMed ID: 11196709
[TBL] [Abstract][Full Text] [Related]
10. A polymorphism in the human cytotoxic T-lymphocyte antigen 4 ( CTLA4) gene (exon 1 +49) alters T-cell activation.
Mäurer M; Loserth S; Kolb-Mäurer A; Ponath A; Wiese S; Kruse N; Rieckmann P
Immunogenetics; 2002 Apr; 54(1):1-8. PubMed ID: 11976786
[TBL] [Abstract][Full Text] [Related]
11. CTLA-4 exon 1 polymorphism in patients with autoimmune blood disorders.
Pavkovic M; Georgievski B; Cevreska L; Spiroski M; Efremov DG
Am J Hematol; 2003 Feb; 72(2):147-9. PubMed ID: 12555221
[TBL] [Abstract][Full Text] [Related]
12. CTLA4 promoter and exon 1 dimorphisms in multiple sclerosis.
Harbo HF; Celius EG; Vartdal F; Spurkland A
Tissue Antigens; 1999 Jan; 53(1):106-10. PubMed ID: 10082437
[TBL] [Abstract][Full Text] [Related]
13. Association of common T cell activation gene polymorphisms with multiple sclerosis in Australian patients.
Teutsch SM; Booth DR; Bennetts BH; Heard RN; Stewart GJ
J Neuroimmunol; 2004 Mar; 148(1-2):218-30. PubMed ID: 14975605
[TBL] [Abstract][Full Text] [Related]
14. Cytotoxic T lymphocyte antigen-4 (CTLA-4) gene polymorphisms and susceptibility to type 1 autoimmune hepatitis.
Agarwal K; Czaja AJ; Jones DE; Donaldson PT
Hepatology; 2000 Jan; 31(1):49-53. PubMed ID: 10613727
[TBL] [Abstract][Full Text] [Related]
15. The CTLA-4 gene is associated with multiple sclerosis.
Ligers A; Xu C; Saarinen S; Hillert J; Olerup O
J Neuroimmunol; 1999 Jun; 97(1-2):182-90. PubMed ID: 10408973
[TBL] [Abstract][Full Text] [Related]
16. Cytotoxic T-lymphocyte antigen-4 (CTLA-4) gene polymorphism and susceptibility to non-Hodgkin's lymphoma.
Monne M; Piras G; Palmas A; Arru L; Murineddu M; Latte G; Noli A; Gabbas A
Am J Hematol; 2004 May; 76(1):14-8. PubMed ID: 15114591
[TBL] [Abstract][Full Text] [Related]
17. Genetic interaction of CTLA-4 with HLA-DR15 in multiple sclerosis patients.
Alizadeh M; Babron MC; Birebent B; Matsuda F; Quelvennec E; Liblau R; Cournu-Rebeix I; Momigliano-Richiardi P; Sequeiros J; Yaouanq J; Genin E; Vasilescu A; Bougerie H; Trojano M; Martins Silva B; Maciel P; Clerget-Darpoux F; Clanet M; Edan G; Fontaine B; Semana G
Ann Neurol; 2003 Jul; 54(1):119-22. PubMed ID: 12838528
[TBL] [Abstract][Full Text] [Related]
18. CTLA-4 gene polymorphisms in systemic lupus erythematosus: a highly significant association with a determinant in the promoter region.
Hudson LL; Rocca K; Song YW; Pandey JP
Hum Genet; 2002 Oct; 111(4-5):452-5. PubMed ID: 12384790
[TBL] [Abstract][Full Text] [Related]
19. Polymorphisms of the CTLA-4 exon 1 and promoter gene in systemic lupus erythematosus.
Lee YH; Kim YR; Ji JD; Sohn J; Song GG
Lupus; 2001; 10(9):601-5. PubMed ID: 11678447
[TBL] [Abstract][Full Text] [Related]
20. CTLA4 dimorphisms and the multiple sclerosis phenotype.
Masterman T; Ligers A; Zhang Z; Hellgren D; Salter H; Anvret M; Hillert J
J Neuroimmunol; 2002 Oct; 131(1-2):208-12. PubMed ID: 12458054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
